Samsung Bioepis Responds To Rumor Of Biogen Biosimilars Buyout
Korean Media Suggests Former Partner Could Acquire Remaining Biosimilars Business
Samsung Bioepis is rumored to be considering a bid for Biogen’s biosimilars business • Source: Shutterstock 
